Join us, Justin Tomlinson and Thomas Reichart, as we sit down with Onaiza Jilani Cadoret-Manier, Chief Executive Officer and President of a biotech startup currently in ‘stealth-mode'. We discuss the power of prioritizing and blending strategy with operations, Onaiza's leadership principles drawn from her youth, and the future of healthcare driven by AI and bioengineering innovations.

Onaiza is a seasoned operator, board member, and advisor with a proven track record of building and leading successful teams in the Bio/Pharma/Life Sciences industry. With nearly 30 years of experience, she has driven growth for both Fortune 500 companies and startups, including Pfizer, Genentech, Amylin, GRAIL, and Ionis. Her expertise spans corporate strategy, business development, commercialization, and operations. She is recognized for her leadership, negotiation skills, and ability to catapult new product growth. Onaiza also brings platform and multi-modality expertise, with deep knowledge across diverse disease areas such as immunology, pulmonology, neurology, and rare diseases.